PRONOXIS
ProNoxis develops, produces and markets novel treatments for autoimmune disorders where modification of NADPH oxidase (NOX2) activity is one key for diseases like rheumatoid arthritis, multiple sclerosis and inflammatory bowel disease (IBD). ProNoxis is a spin-out from Redoxis.
PRONOXIS
Industry:
Biotechnology
Founded:
2009-01-01
Address:
Göteborg, Vastra Gotaland, Sweden
Country:
Sweden
Website Url:
http://www.pronoxis.com
Total Employee:
1+
Status:
Active
Contact:
46-709-164608
Technology used in webpage:
Viewport Meta Google Font API Google Maps Mobile Optimized Shutterstock One.com Website Builder
Similar Organizations
Atlas Antibodies
Atlas Antibodies develops, produces, and globally markets and sells advanced reagents for biomedical research.
GS Environnement
GS Environnement designs, develops, produces, and markets new technologies for professional kitchens.
Investors List
Karolinska
Karolinska investment in Venture Round - ProNoxis
Lund University Bioscience
Lund University Bioscience investment in Venture Round - ProNoxis
Official Site Inspections
http://www.pronoxis.com
- Host name: webcluster2.webpod12-cph3.one.com
- IP address: 46.30.213.40
- Location: Copenhagen Denmark
- Latitude: 55.6786
- Longitude: 12.5589
- Timezone: Europe/Copenhagen
- Postal: 1052
More informations about "ProNoxis"
pronoxis.com
ProNoxis focuses on the preclinical discovery of small-molecule drugs to treat chronic inflammation, autoimmunity and infections. ProNoxis AB was founded in 2009 by LU Bioscience AB (LUBio), Karolinska Development AB, and Redoxis …See details»
Management | pronoxis.com
Since May 2016, Dr. Olofsson is the CEO of ProNoxis AB, providing exoertice in preclinical drug development and international pattnerships and IP management. Peter was between 2007 …See details»
ProNoxis - Crunchbase Company Profile & Funding
Organization. ProNoxis . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies ... ProNoxis is a spin-out from Redoxis. Lists Featuring …See details»
ProNoxis Company Profile 2024: Valuation, Investors ... - PitchBook
ProNoxis is a Private company. What is ProNoxis’s current revenue? The current revenue for ProNoxis is . How much funding has ProNoxis raised over time? ProNoxis has raised $637K. …See details»
Pronoxis AB Company Profile - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for Pronoxis AB of Trollhättan, Västra Götaland. Get the latest business insights from Dun & Bradstreet.See details»
Pronoxis - Products, Competitors, Financials, Employees, …
Pronoxis is a biotechnology company specializing in the preclinical discovery of small-molecule drugs within the pharmaceutical industry. The company's main focus is on developing …See details»
ProNoxis - Funding, Financials, Valuation & Investors - Crunchbase
Jun 1, 2009 How much funding has this organization raised over time? Show . Announced Date . Transaction Name . Number of ... Money Raised . Lead Investors . Jun 1, 2009: Venture …See details»
ProNoxis Management
ProNoxis Management Peter Olofsson CEO CEO as well and board member of Redoxis AB. He holds a PhD in Medical genetics of complex diseases from Lund University and an executive …See details»
ProNoxis - Crunchbase
ProNoxis develops, produces, and markets novel treatments for autoimmune disorders.See details»
ProNoxis Company Profile - Office Locations, Competitors ... - Craft
ProNoxis has 1 employees at their 1 location. See insights on ProNoxis including office locations, competitors, revenue, financials, executives, subsidiaries and more at Craft.See details»
ProNoxis AB - VentureRadar
ProNoxis is developing new small molecules for the treatment of chronic inflammation, such as rheumatoid arthritis, multiple sclerosis and abdominal inflammation. VentureRadar Research / …See details»
ProNoxis - Overview, News & Similar companies | ZoomInfo.com
ProNoxis AB was founded in 2009 by LU Bioscience AB (LUBio), Karolinska Development AB, and Redoxis AB, as a Redoxis spin-off focusing on developin g anti-inflammatory therapeutics …See details»
ProNoxis - VentureRadar
Similar Companies: Guilded Unknown Privately Held Guilded is the ultimate chat platform for gaming communities. Founded in 2017 by Eli Brown, a former pro gamer who played an …See details»
ProNoxis AB - Lund, Sweden - bionity.com
Nov 13, 2009 ProNoxis develops, produces and markets novel treatments for autoimmune disorders where modification of NADPH oxidase (NOX2) activity is one key for diseases like …See details»
Contact | pronoxis.com
Please contact us if you are interested in collaborating with Pronoxis and testing our small molecules in your models. Contact Pronoxis +46 (0)709 16 46 08. …See details»
ProNoxis - Tech Stack, Apps, Patents & Trademarks - Crunchbase
ProNoxis uses 6 technology products and services including HTML5, Google Fonts, and Apache Server, according to G2 Stack. ProNoxis is actively using 3 technologies for its website, …See details»
Research | pronoxis.com
ProNoxis develops products for the treatment of autoimmune, inflammatory and infectious diseases characterized by a large unmet medical need and either large patient populations or …See details»
News | pronoxis.com
2024-03-13. Pronoxis ownerhip changes. The CRO company Redoxis have as result of more focused strategy for research services and expension as international recognised CRO, …See details»
Research programme: NOX2 activators - ProNoxis - AdisInsight
ProNoxis AB, a subsidiary of Redoxis, is developing orally administered, small molecule compounds that selectively activate NOX2 (NADPH oxidase complex), forSee details»
Research - Pronoxis
ProNoxis Research Our mission is to develop a suitable drug for oral administration in human patients suffering from autoimmune inflammatory disease. Autoimmune diseases are …See details»